Guanylin peptides and colorectal cancer (CRC)

Biomedicine and Pharmacotherapy

Volumn 62, Issue 2, 2008, Pages 70-76

  Camici, Marcello ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Colorectal cancer; Guanylin peptides

Indexed keywords

CYCLIC GMP; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANYLATE CYCLASE ACTIVATOR; GUANYLATE CYCLASE C RECEPTOR; GUANYLATE CYCLASE C RECEPTOR AGONIST; GUANYLIN; ION CHANNEL; MESSENGER RNA; PHOSPHODIESTERASE; PROTEIN KINASE; SULINDAC SULFONE; UNCLASSIFIED DRUG; UROGUANYLIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLON CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; DIAGNOSTIC APPROACH ROUTE; HUMAN; HUMAN CELL; INTESTINE EPITHELIUM; INTRACELLULAR TRANSPORT; NONHUMAN; PEPTIDE ANALYSIS; PRIORITY JOURNAL; RAT; SECOND MESSENGER;

ANIMALS; COLORECTAL NEOPLASMS; CYCLIC GMP; GASTROINTESTINAL HORMONES; GUANYLATE CYCLASE; HUMANS; ION CHANNELS; NATRIURETIC PEPTIDES; PHOSPHORIC DIESTER HYDROLASES; PROTEIN KINASES; RECEPTORS, PEPTIDE; SIGNAL TRANSDUCTION;

EID: 38949115909     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2007.04.010     Document Type: Article

References (65)

1. In: Toms J.R. (Ed). Cancer Stats Monograph 2004 (2004), Cancer Research UK, London
2. O'Connell J.B., Maggard M.A., and Liv J.H. Rates of colon and rectal cancers are increasing in young adults. Am Surg 69 10 (2003) 866-872
3. Kindler H.L., and Shulman K.L. Metastatic colorectal cancer. Curr Treat Options Oncol 2 6 (2001) 459-471
4. Finlay I.G., Meck D., and Burton F. Growth rate of hepatic metastases in colorectal cancer. Br J Surg 75 (1988) 641-644
5. Bettowski J. Guanylin and related peptides. J Physiol Pharmacol 52 3 (2001) 351-375
6. Forte L.R. A novel role for uroguanylin in the regulation of sodium balance. J Clin Invest 112 (2003) 1138-1141
7. Kokot F., and Ficek R. Guanylins are they of nephrological relevance?. Nephron 84 (2000) 201-205
8. Forte L.R., London R.M., Freeman R.H., and Krause W.J. Guanylin peptides: renal actions mediated by cyclic GMP. Am J Physiol Renal Physiol 278 (2000) F180-f191
9. Greenberg R.N., Hill M., Crytzer J., Krause W.J., Ebert S.L., and Forte L.R. Comparison of effects of uroguanylin and Escherichia coli heat-stable enterotoxin Sta in mouse intestine and kidney: evidence that uroguanylin is an intestinal natriuretic hormone. J Invest Med 45 5 (1997) 276-283
10. Nakasato M. Guanylin family: new intestinal peptides regulating electrolyte and water homeostasis. J Gastroenterol 36 (2001) 219-225
11. Sindic A., and Schlatter E. Cellular effects of guanylin and uroguanylin. J Am Soc Nephrol 17 (2006) 607-616
12. Kuhn M. Molecular physiology of natriuretic peptide signalling. Basic Res Cardiol 99 (2004) 76-82
13. Steinbrecher K.A., Wowk S.A., Rudolph J.A., Witte D.P., and Cohen M.B. Targeted inactivation of the mouse guanylin gene results in altered dynamics of colonic epithelial proliferation. Am J Pathol 161 6 (2002) 2169-2178
14. Steinbrecher K.A., Tuohy T.M.F., Goss K.H., Scott M.C., Witte D.P., Groden J., et al. Expression of guanylin is down regulated in mouse and human intestinal adenomas. Biochem Biophys Res Commun 273 (2000) 101-108
15. Pitari G.M., Guglielmo M.D., Park J., Schulz S., and Waldman S.A. Guanylin cyclase C agonists regulate progression through the cell cycle of human carcinoma cells. Proc Natl Acad Sci USA 98 (2001) 7846-7851
16. Suhasimi M., Li H., Lohmann S.M., Boss G.R., and Pilz R.B. Cyclic GMP-dependent protein kinase inhibits the ras/mitogen-activated protein kinase pathway. Mol Cell Biol 18 (1998) 6983-6994
17. Shailubhai K., Yu H.H., Karunanandac K., Wang J.Y., Eber S.L., Wang Y., et al. Uroguanylin treatment suppresses polyp formation in the Apc(min/ positive) mouse and induces apoptosis in human colon adenocarcinoma cells via cyclic GMP. Cancer Res 60 (2000) 5151-5157
18. Shiff S.J., Koutsos M.I., Qiao L., and Rigas B. Nonsteroidal antiinflammatory drugs inhibit the proliferation of colon adenocarcinoma cells: effects on cell cycle and apoptosis. Exp Cell Res 222 (1996) 179-188
19. Laney Jr. D.W., Mann E.A., Dellen S.C., Perkins D.R., Giannella R., and Cohen M.B. Novel sites for expression of an Escherichia coli heat-stable enterotoxin receptor in the developing rat. Am J Physiol 263 (1992) G815-G821
20. Laney Jr. D.W., Bezzera J.A., Kosiba J.L., Degen S.J.F., and Cohen M.B. Upregulation of Escherichia coli heat-stable eneterotoxin receptor in regenerating rat liver. Am J Physiol 266 (1994) G899-G906
21. Tram-Paterson R., Davin D., Krauss R.D., rado T.A., and Miller D.M. Expression and regulation of the cystic fibrosis gene during rat liver regeneration. Am J Physiol 263 (1992) C55-C60
22. Sharma R.K. Evolution of the membrane guanylate cyclase transduction system. Mol Cell Biochem 203 (2002) 3-30
23. Padayatti P.S., Pattanai K., Ma X., and van den Akker F. Paharmacol Ther 104 (2004) 83-89
24. Lucas K.A., Pitari G.M., Kateroumian S., Ruiz-Stewart I., Park S., Schulz S., et al. Guanylyl cyclases and signaling by cyclic GMP. Pharmacol Rev 52 3 (2000) 375-414
25. Lugnier C. Cyclic nucleotide phosphodiesterase (PDE) superfamily: a new target for the development of specific therapeutic agents. Pharmacol Ther 109 3 (2006) 366-398
26. Smolenski A., Burkardt A.M., and Eigenthaler M. Functional analysis of cGMP-dependent protein kinase I and II as mediators of NO/cGMP effects. Naunyn-Schmiedebergs Arch Pharmacol 358 (1998) 134-139
27. Lincoln T.M., and Cornwell T.L. Intracellular cyclic GMP receptor proteins. FASEB J 7 (1993) 328-338
28. Ruth P. Cyclic GMP-dependent protein kinases: understanding in vivo functions by gene targeting. Pharmacol Ther 82 (1999) 355-372
29. Jarchau T., Hausler C., and Market T. Cloning, expression and in situ localisation of rat intestinal cGMP-dependent protein kinase II. Proc Natl Acad Sci USA 91 (1994) 9426-9430
30. Stacey P., Rulten S., Dapling A., and Phillips S.C. Molecular cloning and expression of human cGMP-binding cGMP-specific phosphodiesterase. (PDE5). Biochem Biophys Res Commun 247 (1988) 249-254
31. Piazza G.A., Xu S., and Klein-Szato A. Overexpression of cGMP phosphodiesterase in colonic neoplasias compared to normal mucosa. Gastroenterology 118 (2000) A282
32. Deguchi A., Thompson W.J., and Weinstein L.B. Activation of protein kinase G is sufficient to induce apoptosis and inhibit cell migration in colon cancer cells. Cancer Res 64 (2004) 3966-3973
33. Thompson W.J., Piazza G.A., and Li H. Exisulind induction of apoptosis involves guanosine 3′-5′ cyclic monophosphate phosphodiesterase inhibition, protein kinase G activation and attenuated beta-catenin. Cancer Res 60 (2000) 3338-3342
34. Soh J.W., Mao Y., and Kim M. Cyclic GMP mediates apoptosis induced by sulindac derivatives via activation of c-Jun NH2-terminal Kinase 1. Clin Cancer Res 6 (2000) 4136-4141
35. Liu H., Xiong Z., and Sperelakis N. Cyclic nucleotides regulate the activity of L-type calcium channels in smooth muscle cells from rat portal vein. J Mol Cell Cardiol 29 (1997) 1411-1421
36. Matulef K., and Zagotta W.N. Cyclic nucleotide-gated ion channels. Annu Rev Cell Dev Biol 19 (2003) 23-44
37. Berridge M.J., Bootman M.D., and Lipp P. Calcium- a life and death signal. Nature 395 (1998) 645-648
38. Bhaattacharya J., and Chakrabarti M.K. Biochim Biophys Acta 1403 (1998) 1-4
39. Pitari M.G., Zingman L.V., Hodgson D.M., Alekseev A.E., Kazerounian S., Bienegroeber M., et al. Bacterial enterotoxin are associated with resistance to colon cancer. Proc Natl Acad Sci USA 5 (2003) 2695-2699
40. Pitari G.M., Baksh R.I., Harris D.M., Li P., Kazeroinian S., and Waldman S.A. Interruption of homology desensitization in cyclic guanosine 3′-5′-monophosphate signaling restores colon cancer cytostasis by bacterial enterotoxins. Cancer Res 65 (2005) 11129-11135
41. Giovannucci E., Rimm E.B., Stampfer M.J., Colditz G.A., Ascherio A., and Willet W.C. Aspirin use and the risk of colorectal cancer and adenoma in male health professionals. Ann Intern Med 121 (1994) 241-246
42. Soh J.W., and Weinstein I.B. Role of COX-independent targets of NSAIDs and related compounds in cancer prevention and treatment. Prog Exp Tumor Res 37 (2003) 261-285
43. Agoff S.N., Brentnall T.A., and Crispin D.A. The role of cyclooxygenase 2 in ulcerative colitis-associated neoplasia. Am J Pathol 157 (2000) 737-745
44. Pitari G.M., Li T., Baksh R.I., and Waldman S.A. Exisulind and guanylyl cyclase C induce distinct antineoplastic signaling mechanisms in human colon cancer cells. Mol Cancer Ther 5 5 (2006) 1190-1196
45. Xiao D., Degichi A., Gundersen G.G., Oehlen B., Arnold L., and Weinstein I.B. The sulindac derivatives OSI-461, OSIP486823 and OSIP487703 arrest colon cancer cells in mitosis by causing microtubule depolymerization. Mol Cancer Ther 5 1 (2006) 60-67
46. Carrithers S.L., Parkinson S.J., Goldstein S., Park P., Robertson D.C., and Waldman S.A. Escherichia coli heat-stable toxin receptors in human colonic tumors. Gastroenterology 107 (1994) 1653-1661
47. Carrithers S.L., Barber M.T., and Biswas S. Guanylyl cyclase C is a selective marker for metastatic colorectal tumors in human extraintestinal tissues. Proc Natl Acad Sci USA 93 (1996) 14827-14832
48. Carrithers S.L., Parkinson S.J., Goldstein S.D., Park P.K., Urbanski R.W., and Waldman S.A. Escherichia coli heat-stable enterotoxin receptors. A novel marker for colorectal tumors. Dis Colon Rectum 39 (1996) 171-181
49. Bustin S.A., Gyselman V.G., Williams N.S., and Dorudi S. Detection of cytoskeleton 19/20 and guanylyl cyclase C in peripheral blood of colorectal cancer patients. Br J Cancer 79 (1999) 1813-1820
50. Fava T.A., Desnoyers R., and Schulz S. Ectopic expression of guanylyl cyclase C in CD 34 progenitor cells in peripheral blood. J Clin Oncol 19 (2001) 3951-3959
51. Chen G., McIver C.M., and Texler M. Detection of occult metastasis in lymph nodes from colorectal cancer patients: a multiple-marker reverse transcriptase-polymerase chain reaction. Dis Colon Rectum 47 (2004) 679-686
52. Salto-Tellez M., Kong S.L., Leong A.P., and Koay E.S. Intrinsic variability in the detection of micrometastases in lymph nodes for re-staging of colorectal cancer Effect of individual markers and tissue samples. Eur J Cancer 39 (2003) 1234-1241
53. Frick G.S., Pitari G.M., Weinberg D.S., Hyslop J., Schultz S., Waldman S.A., et al. a molecular marker for staging and postoperative surveillance of patients with colorectal cancer. Expert Rev Mol Diagn 5 5 (2005) 701-713
54. Cagir B., Gelmann A., and Park J. Guanylyl cyclase C messenger RNA is a biomarker for recurrent stage II colorectal cancer. Ann Intern Med 131 (1999) 805-812
55. Giblin M.F., Gali H., Sieckman G.L., Owen N.K., Hoffman T.J., and Forte L.R. In vitro and in vivo comparison of human ST peptides analogues incorporating 111I-DOTA group and distinct linker moieties. Biconjug Chem 15 (2004) 872-880
56. Wolfe H.R., Mendizabal M., Lleong E., Curthberkson A., Desai V., and Pullan S. In vivo imaging of human colon cancer xenografts in immunodeficient mice using a guanylyl cyclase C-specific ligand. J Nucl Med 43 (2002) 392-399
57. Cohen M.B., Hawkins J.A., and Witte D.P. Guanylin mRNA expression in human intestine and colorectal adenocarcinoma. Lab Invest 78 (1998) 101-108
58. Soderling S.H., and Beavo J.A. Regulation of cAMP and cGMP signaling: new phosphodiesterases and new functions. Curr Opin Cell Biol 12 (2000) 174-179
59. Francis S.H., and Corbin J.D. Molecular mechanisms and pharmacokinetics of phosphodiesterase-5 antagonists. Curr Urol Rep 4 (2003) 457-465
60. Urbanski R., Carrithers S.L., and Waldman S.A. Internalization of E. coli ST mediated by guanylyl cyclase C in T84 human colon carcinoma cells. Biochim Biophys Acta 1245 (1995) 29-36
61. Garman K.S., Jeffreys A., Coffman C., and Fisher D.A. Colorectal cancer screening, comorbidity and follow-up in elderly patients. Am J Med Sci 332 4 (2006) 159-163
62. Nikolaev V.O., Gambaryan S., and Lohse M.J. Fluorescent sensors for rapid monitoring of intracellular cGMP. Nat Methods 3 (2006) 23-25
63. Ventura A., Kirsh D.G., McLaughlin M.E., Tuveson D.A., Grimm J., Lintault L., et al. Restoration of p53 function leads to tumor regression in vivo. Nature on-line (January 2007) 1-5
64. Gran M.V., Baron J.A., Sandler R.S., Wallace K., Haile R.W., Church T.R., et al. Prolonged effect of calcium supplementation on risk of colorectal adenomas in a randomized trial. J Natl Cancer Inst 99 (2007) 129-136
65. Baron J., Beach M., Mandel J., van Stolk R., and Sandler R. Calcium supplements for prevention of colorectal adenomas. N Engl J Med 340 (1999) 101-107